← All companies
Cullinan Therapeutics, Inc.
CGEM - CIK 0001789972
Market cap$740.57 M
Rank#2664
SEC filings435
Cullinan Therapeutics, Inc. trades as CGEM and has a market capitalization of $740.57 M, making it the #2664 largest US-listed company by market value. This page tracks Cullinan Therapeutics, Inc. through 435 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$0.00FY 2022
Net income (latest FY)-$219.88MFY 2025
Operating cash flow (latest FY)-$175.75MFY 2025
Total assets (latest FY)$448.37MFY 2025
Financial performance
Key statistics
- Market cap
- $740.57 M
- Share price (derived)market cap / shares outstanding
- $12.05
- EPS (diluted)FY 2023
- $-3.69
- Shares outstandingas of 2026-04-30
- 0.06B
- Total equityas of 2025-12-31
- $408.73M
- Return on equity
- -53.8%
- Cash & equivalentsas of 2026-03-31
- $75.08M
- Stock buybacksFY 2020
- $6.57M
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| Insider trade | 4 | 2026-05-06 |
| Insider sale notice | 144 | 2026-05-05 |
| S-3ASR | - | 2026-04-28 |
| Proxy materials | DEFA14A | 2026-04-28 |
Similar companies
The largest companies sharing Cullinan Therapeutics, Inc.'s SEC industry classification (biological products, (no diagnostic substances)).
Frequently asked questions
What is Cullinan Therapeutics, Inc.'s market cap?
Cullinan Therapeutics, Inc. (CGEM) has a market capitalization of $740.57 M as of 2026-06-11, ranking #2664 among US-listed companies.
Is Cullinan Therapeutics, Inc. profitable?
In its latest fiscal year Cullinan Therapeutics, Inc. reported a net loss of $219.88M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.